Xueqin Song, Ph.D. - Publications
Affiliations: | 2002 | University of Kentucky, Lexington, KY |
Area:
Pharmacy, Pharmacology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2002 | Zhu J, Song X, Lin HP, Young DC, Yan S, Marquez VE, Chen CS. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. Journal of the National Cancer Institute. 94: 1745-57. PMID 12464646 DOI: 10.1093/Jnci/94.23.1745 | 0.584 | |||
2002 | Johnson AJ, Hsu AL, Lin HP, Song X, Chen CS. The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. The Biochemical Journal. 366: 831-7. PMID 12076251 DOI: 10.1042/Bj20020279 | 0.562 | |||
2002 | Song X, Lin HP, Johnson AJ, Tseng PH, Yang YT, Kulp SK, Chen CS. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. Journal of the National Cancer Institute. 94: 585-91. PMID 11959891 DOI: 10.1093/Jnci/94.8.585 | 0.595 | |||
2001 | Johnson AJ, song X, Hsu A, Chen C. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells. Advances in Enzyme Regulation. 41: 221-35. PMID 11384747 DOI: 10.1016/S0065-2571(00)00015-7 | 0.43 | |||
2000 | Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. The Journal of Biological Chemistry. 275: 11397-403. PMID 10753955 DOI: 10.1074/Jbc.275.15.11397 | 0.588 | |||
Show low-probability matches. |